Insolvency Notices

Company

NEXIS PHARMA LTD

Notice Type
Notice of Intended Dividends
Publication date
26/07/2021
Edition
The London Gazette
Notice ID
3850965
Notice Code
2406

NEXIS PHARMA LTD

07530469

Registered office: C/O Mazars LLP, 1st Floor, Two Chamberlain Square, Birmingham, B3 3AX

Principal trading address: Units 25-26 Kimberley Business Park, Kimberley Way, Brereton, Rugeley, WS15 1RE

Notice is hereby given pursuant to Rule 14.28 Insolvency (England and Wales) Rules 2016 that the Joint Liquidators intend to declare a final dividend to unsecured creditors of the Company within the period of two months from the last date for proving specified below.

Creditors who have not yet done so must prove their debts by delivering their proofs (in the format specified in Rule 14.4) to the Joint Liquidators at 1st Floor, Two Chamberlain Square, Birmingham, B3 3AX by no later than 18 August 2021 (the last date for proving).

Creditors who have not proved their debt by the last date for proving may be excluded from the benefit of this dividend or any other dividend declared before their debt is proved.

Date of Appointment: 22 January 2020

Office Holder Details: Scott Christian Bevan (IP No. 9614) and Simon David Chandler (IP No. 008822) both of Mazars LLP, 1st Floor, Two Chamberlain Square, Birmingham, B3 3AX

The Joint Liquidators can be contacted on Tel: 0121 2329 629. Alternative contact: Liam Flavell

Scott Christian Bevan, Joint Liquidator

22 July 2021

Ag GH41794